M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of Additional Courses of Rituximab in Patients With Active Rheumatoid Arthritis An Open-Label Extension Analysis
Edward C. Keystone,Roy Fleischmann,Paul Emery,Daniel E. Furst,Ronald F van Vollenhoven,Joan M. Bathon,Maxime Dougados,Andrew R. Baldassare,Gianfranco Ferraccioli,Andrew Chubick,James Udell,M. Cravets,Sunil Agarwal,Simon Cooper,Fabio Magrini +14 more
TL;DR: Findings indicate that patients treated with repeated courses of rituximab have sustained clinical responses with no new adverse events.
Journal ArticleDOI
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
Maxime Dougados,Minh Vu Chuong Nguyen,L. Berdah,Bernard Mazières,Eric Vignon,Michel Lequesne +5 more
TL;DR: It is confirmed that the demonstration of a structure-modifying effect in hip OA is feasible, and shows, for the first time, that treatment with diacerein for 3 years has a significant structure- modifying effect as compared with placebo, coupled with a good safety profile.
Journal ArticleDOI
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report
Tuhina Neogi,Daniel Aletaha,Alan J. Silman,Raymond L. Naden,David T. Felson,Rohit Aggarwal,Clifton O. Bingham,Neal S. Birnbaum,Gerd R Burmester,Vivian P. Bykerk,Marc D. Cohen,Bernard Combe,Karen H. Costenbader,Maxime Dougados,Paul Emery,Gianfranco Ferraccioli,Johanna M. W. Hazes,Kathryn Hobbs,Tom W J Huizinga,Arthur Kavanaugh,Jonathan Kay,Dinesh Khanna,Tore K Kvien,Timothy J. Laing,Katherine P. Liao,Philip J. Mease,Henri A. Ménard,Larry W. Moreland,Raj Nair,Theodore Pincus,Sarah Ringold,Josef S Smolen,Ewa Stanislawska-Biernat,Deborah P M Symmons,Paul P. Tak,Katherine S. Upchurch,Jiří Vencovský,Frederick Wolfe,Gillian A. Hawker +38 more
TL;DR: The expert panel agreed that the new classification criteria should be applied to individuals with undifferentiated inflammatory arthritis in whom at least 1 joint is deemed by an expert assessor to be swollen, indicating definite synovitis.
Journal Article
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Anneke Spoorenberg,D. van der Heijde,E de Klerk,Maxime Dougados,K. de Vlam,Herman Mielants,H van der Tempel,S van der Linden +7 more
TL;DR: It is concluded that neither CRP nor ESR is superior to assess disease activity, and the positive predictive values of CRP and ESR in the setting were low.
Journal Article
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
TL;DR: To select specific instruments for each domain of the core set for endpoints in ankylosing spondylitis (AS), all instruments described in the literature to assess the domains chosen as endpoints were gathered and sent to 43 members of the Assessments in Ankyl losing Spondylopathy (ASAS) Working Group.